Prestige Consumer Healthcare (PBH) EBITDA Margin (2010 - 2025)
Prestige Consumer Healthcare (PBH) posted quarterly EBITDA Margin of 29.1% for Q4 2025, down 257.0% year-over-year from 18.54% in Q4 2024, and little changed quarter-over-quarter from 29.06% in Q3 2025.
Prestige Consumer Healthcare (PBH) EBITDA Margin (2010 - 2025) Analysis & Trends
Prestige Consumer Healthcare's EBITDA Margin history runs 16 years deep, the most recent figure standing at 29.1% for Q4 2025.
- In Q4 2025, EBITDA Margin fell 257.0% year-over-year to 29.1%; the TTM figure through Dec 2025 stood at 29.21% (down 35.0% YoY), while the FY2025 annual figure was 29.6%, down 83.0% from the prior year.
- EBITDA Margin for Q4 2025 stood at 29.1%, roughly flat from 29.06% in the prior quarter.
- The five-year high for EBITDA Margin was 33.93% in Q2 2021, with the low at 98.3% in Q1 2023.
- The 5-year median for EBITDA Margin is 29.77% (2024), against an average of 23.6%.
- The sharpest annual moves came in 2023 and 2024: EBITDA Margin plunged 12730 bps in 2023, then soared 12795 bps in 2024.
- Prestige Consumer Healthcare's EBITDA Margin stood at 30.09% in 2021, then advanced by 5 bps to 31.64% in 2022, then declined by 3 bps to 30.71% in 2023, then rose by 3 bps to 31.68% in 2024, then decreased by 8 bps to 29.1% in 2025.
- Business Quant data shows PBH's EBITDA Margin at 29.1% in Q4 2025, 29.06% in Q3 2025, and 28.76% in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.89 Bn | 42.93 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.01 Bn | 39.35 Bn | 2.15 Bn | -5.58% |
| 3 | Zoetis | 31.52 Bn | 29.84 Bn | 1.05 Bn | 33.91% |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | 16.51% |
| 5 | United Therapeutics | 22.17 Bn | 19.51 Bn | 683.80 Mn | 42.23% |
| 6 | Viatris | 18.73 Bn | 17.85 Bn | 1.46 Bn | 0.17% |
| 7 | Neurocrine Biosciences | 15.51 Bn | 15.12 Bn | 935.80 Mn | 15.80% |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 18.13% |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.96 Bn | - | - |
| 10 | Prestige Consumer Healthcare | 2.43 Bn | 2.37 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 29.10% |
| Sep 30, 2025 | 29.06% |
| Jun 30, 2025 | 28.76% |
| Mar 31, 2025 | 29.82% |
| Dec 31, 2024 | 31.68% |
| Sep 30, 2024 | 29.72% |
| Jun 30, 2024 | 26.97% |
| Mar 31, 2024 | 29.66% |
| Dec 31, 2023 | 30.71% |
| Sep 30, 2023 | 30.82% |
| Jun 30, 2023 | 30.50% |
| Mar 31, 2023 | -98.30% |
| Dec 31, 2022 | 31.64% |
| Sep 30, 2022 | 29.17% |
| Jun 30, 2022 | 31.41% |
| Mar 31, 2022 | 29.01% |
| Dec 31, 2021 | 30.09% |
| Sep 30, 2021 | 28.44% |
| Jun 30, 2021 | 33.93% |
| Mar 31, 2021 | 29.84% |